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Summary
Purpose: Sea macroalgae are an important source of bio-
logically highly valuable compounds. The main aim of this 
study was to investigate the in vitro anticancer properties and 
chemical composition of the dichloromethane-methanol ex-
tract and three fractions of the Fucus spiralis from coastline of
Morocco. 
Methods: Fractions were made from dichloromethane: metha-
nol (1:1) extract of Fucus spiralis: petroleum-ether, ethyl-ace-
tate and n-butanol. Extract and fractions were screened for in 
vitro cytotoxicity by MTT assay against human cervical ad-
enocarcinoma (HeLa), colorectal adenocarcinoma (LS-174T), 
lung carcinoma (A549), and normal human lung fibroblasts 
(MRC-5). Cell cycle distribution of the HeLa cells was evalu-
ated using flow cytometry. Acridine orange (AO)-ethidium bro-
mide (EB) staining was used to assess morphological changes 
of HeLa cells under fluorescence microscope. Anti-migration 
and anti-angiogenic properties were investigated using scratch 
and tube formation assays against human endothelium-de-
rived permanent EA.hy926 cell line. Antidiabetic activity was 
tested using anti-α-glucosidase assay. Antimicrobial effect was 
tested using micro- dilution method. 
Results: Petroleum-ether fraction оf Fucus spiralis rich in 
fatty acids exerted the highest cytotoxicity against HeLa 
cells. Ethyl-acetate and petroleum-ether fractions induced the 
highest accumulation of the HeLa cells in sub-G1 and G2/M 
phases. Extract and fractions showed proapoptotic effect on 
HeLa cells under fluorescent microscope. They exhibited an-
timigratory and antiangiogenic effects in vitro. IC50 value 
for α-glucosidase inhibitory activity was much stronger than 
standard acarbose. n-Butanol fraction exerted the highest an-
tibacterial and antifungal activity.
Conclusions: The investigation of various biological activities 
of the extract and fractions obtained from Fucus spiralis may 
suggest a promising anticancer and pharmacological potential 
of this edible macroalga.
Key words: cancer, cytotoxic, fatty acids, Fucus spiralis, can-
cer cells, in vitro
Introduction
 Macroalgae have been explored and used not 
only as food but also as medicinal and pharma-
ceutical natural agents. It has been reported that 
macroalgae have anticancer properties including 
cytotoxic and antimitogenic [1]. One of the active 
substances isolated from macroalgae Bryopsis sp., 
kahalalide F, was investigated in phase 2 clinical 
trials for malignant melanoma, liver, prostate, and 
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breast cancer [1-3]. The trial was discontinued in 
patients with malignant melanoma due to lack of 
objective response [2]. It was also found that this 
substance exhibited antitumor effect against lung, 
colon and prostate cancer [1].
 Macroalgae produce bioactive components in 
order to endure harsh environmental conditions: 
fatty acids, vitamins, proteins, essential amino ac-
ids, dietary fibers, polysaccharides, phlorotannins 
(unique phenolic compounds) and secondary me-
tabolites as chemical defense and cell wall structure 
as defense from herbivores [4]. These metabolites 
might be medicinally useful for the treatment or 
prevention of different diseases, including cancer [5].
 Bioactive components that have been isolated 
from the brown algae are polysaccharides, alginic 
acid, laminarians and fucoidans (sulfated polysac-
charides with antiviral, immunomodulating and 
antitumor activity) [5,6]. Fucoidan isolated from 
brown algae induced apoptosis of human colon 
cancer cells in vitro [7]. 
 Edible brown macroalga Fucus spiralis Lin-
naeus (Phaeophyta) inhabits littoral shores of Eu-
rope and North America. It is found along the At-
lantic coast of France, Spain, Morocco and Azores. 
Specific microclimate on the Sidi Bouzid location 
in Morocco (strong and freezing cold ocean cur-
rent) makes this brown alga rich in unique second-
ary metabolites [8].
 Fucus spiralis was found to have a high content 
of biologically active compounds: phloroglucinol, 
mannitol, oleic acid, fucosterol, arachidonic and 
eicosapentaenoic acids [5]. There is an increasing 
interest for using brown macroalgae in nutrition, 
due to their potent antioxidative activities. It is 
well-known that Fucus spiralis has an important 
place in the food chain of Mediterranean countries 
[5]. Polyphenolic compounds have been shown to 
exert numerous health-beneficial effects. Their an-
tioxidative and antidiabetic properties had been 
reported [9]. The polyphenols may have a prom-
ising anticancer potential, since they can induce 
cell cycle arrest and apoptosis, inhibit angiogenesis 
and reduce metastatic potential of cancer cells [10]. 
Fatty acids, which may exert inhibitory effects on 
the development and progression of cancer, may 
be also helpful in the prevention and treatment 
of diabetes type 2 and cardiovascular diseases and 
also they may be used as potential antimicrobial 
and anti-inflammatory agents [11,12]. 
 There is a link between diabetes and cancer. 
People with diabetes have increased risk of sev-
eral types of cancer (female reproductive organs, 
colorectal, breast, liver, urinary tract and pancreas) 
and their mortality is also increased. Patients with 
diabetes are often troubled with hyperglycemia, 
obesity and increased oxidative stress, which are 
factors that can also lead to increased cancer risks 
[13]. Furthermore, commercial antidiabetic medi-
cations, such as acarbose, have toxic side effects, 
which bring up the search for natural alternatives. 
 People with cancer are more prone to microbial 
infections which can be multidrug resistant [14]. 
Also, chronic infection can lead to chronic inflam-
mation which could lead to cancer [15]. So it is very 
important to find novel antimicrobial agents that 
can alone or with combination of known antibiot-
ics and antimycotics contribute to eradication of 
multidrug resistance that can be fatal. 
 The main aim of this research was to investi-
gate the anticancer effects of the dichlormethane-
methanol extract and fractions obtained from Fucus 
spiralis collected at the Sidi Bouzid on the Atlantic 
coast of Morocco. To further explore their biological 
effects, the antioxidative, antidiabetic, antibacterial 
and antifungal activities were evaluated. In addition, 
the fatty acid composition and total phenolic con-
tent of the extract and fractions were determined. 
Methods 
Algae collection and preparation of extract and fractions 
 Investigated algae were collected at the Atlantic 
coast of Morocco (Sidi Bouzid coast) between March-
April 2014. The examined brown alga was identified as 
Fucus spiralis Linnaeus, at the Laboratoire de Cryptog-
amie, MNHN Paris, France. The specimens were air-dried 
in the dark and powdered. The powder was extracted in 
dichloromethane/methanol (50:50) as described by Cac-
camese and Azzolina [16]. In brief, the powder was ex-
tracted in a solvent overnight at room temperature. The 
resulting extract was centrifuged and the supernatant 
was concentrated to dryness in a rotary evaporator (Hei-
dolph Instruments GmbH & Co., KG, Germany) under re-
duced pressure (at 45°C), until crude extract was obtained 
and was conserved at 4°C. In order to obtain fractions, 
the extract was then suspended in 100 mL of distilled 
water and successively extracted with petroleum ether 
(Pet-Et, 3x100 mL), ethyl-acetate-(EtOAc, 3x100 mL) and 
n-butanol (n-BuOH, 3x100 mL). The obtained extracts and 
fractions were stored at -20°C until further analysis.
Fatty acid assay
 Fatty acids from algae dry petroleum-ether fractions 
were trans-esterified with hydrochloric acid in methanol, 
according to the method described by Ichihara and Fuku-
bayashi, 2010 [17], and fatty acid methyl esters (FAMEs) 
were obtained. Fatty acid methyl esters were further ana-
lyzed using an Agilent Technologies 7890A Gas Chro-
matograph with a flame ionization detector. Separation 
of the FAMEs was performed on a CP-Sil 88 capillary 
column (100 m×0.25 mm×0.2 μm) using helium as a 
carrier gas at a flow rate of 1 mL/min. The samples were 
injected at the starting oven temperature of 80°C, injec-
tor temperature was 250°C, and detector temperature 
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was 270°C. The oven temperature was programmed to 
increase from 80°C, 4°C/min to 220°C, 5 min, 4°C/min 
to 240°C, 10 min. Fatty acids were identified by their 
retention time in comparison with the reference fatty 
acid standards (Supelco FAME Mix, Bellefonte, PA). The 
results were expressed as a percentage of individual 
fatty acid in the total dry petroleum-ether fractions. 
Total phenolic content
 The content of total phenolics in investigating ex-
tracts was analyzed using a modified Folin-Ciocalteu 
method [18]. Results were expressed as milligrams of 
Gallic acid equivalents (GAE) per gram of the investi-
gating extracts based on the standard calibration curve 
obtained with a series of Gallic acid standard solutions. 
Data were presented as mean ± standard deviation (SD) 
of three independent experiments.
DPPH free radical scavenging assay
 The antioxidant activity of the extracts was analyzed 
based on their free radical scavenging activity (RSA) on 
the stable 1, 1-diphenyl-2-picrylhydrazyl (DPPH) radical, 
carried out according to the procedure described pre-
viously [19] with slight modifications. All test experi-
ments were run in three independent experiments and 
data were presented as mean ± SD.
Cytotoxic activity
 The tested cell lines human cervical adenocarcino-
ma (HeLa), colorectal adenocarcinoma (LS-174T), lung 
carcinoma (A549), and normal human lung fibroblasts 
(MRC-5) were grown in RPMI-1640 medium. Somatic 
human umbilical vein endothelial (EA.hy926) cell line 
was grown in Dulbeccos’s modified Eagle’s medium 
(DMEM). The tested cell lines were grown in the com-
plete nutrient medium according to previously described 
procedure for treatment of cancer cell lines [20]. Stock 
solutions (100 mg/mL) of the extract and fractions, made 
in dimethylsulfoxide (DMSO), were dissolved in a cor-
responding medium to the required working concentra-
tions. The final concentrations applied to the cells were 
200, 100, 50, 25 and 12.5 μg/mL. To the control cells 
only the nutrient medium was added. The procedure has 
been already described [20]. The effects of the extract 
and fractions on the cell survival were determined by 
the microculture tetrazolium test (MTT) according to 
Mosmann [21] with modification by Ohno and Abe [22]. 
All experiments were done in triplicate. 
Cell cycle analysis
 HeLa cells were seeded into 6-well plates (200000 
cells per well) and after 24 h they were treated with IC50 
and 2×IC50 concentrations of the investigated extract and 
fractions for 24 h. After incubation, the cells were col-
lected by trypsinization, fixed in 70% ethanol on ice and 
stored at -20ºC for one week [20]. The cells were washed 
with PBS and incubated with RNaseA at 37ºC for 30 min. 
After this, propidium iodide (PI) was added. Cell cycle 
phase distribution was analyzed by FACSCalibur flow 
cytometer (BD Biosciences Franklin Lakes, NJ, USA) us-
ing CELLQuest software.
Fluorescence microscopy
 HeLa cells (50000 cells per well) were seeded into 
6-well plates. The next day, the tested extract and frac-
tions were added to cells at concentrations 2×IC50. After 
24 h of treatment, the cells were stained with a mixture 
of acridine orange (AO)/ethidium bromide (EB) (3 μg/
mL AO and 10 μg/mL EB) in phosphate buffered saline 
(PBS). Photomicrogaphs were taken under a fluorescence 
microscope - Carl Zeiss PALM MicroBeam with AxioO-
bserver.Z1 using AxioCamMRm (filters Alexa 488 and 
568), as previously described [20].
In vitro scratch assay
 EA.hy926 cells were seeded into 24-well plates. 
Confluent cell monolayers were formed after 24 h and 
scratched with a p200 sterile pipette tip to create a 
straight central scratch line, as described earlier [23]. 
After washing with nutrient medium, cells were treated 
with subtoxic concentrations (IC20) of extracts and frac-
tions for 24 h. Photomicrographs were captured immedi-
ately after making the wound and then 24 h later under 
inverted phase-contrast microscope. The experiments 
were carried out in triplicate and the results are shown 
as mean ± SD.
Tube formation assay
 EA.hy926 cells were plated on the surface of the 
24-well plates, coated with 200 μL of Corning®Matrigel® 
basement membrane matrix. The assay was described 
previously elsewhere [23]. Afterwards, in control wells 
with cells, DMEM was added, while solutions of sub-
toxic concentrations (IC20) of extract and fractions were 
added to other wells. After 20-h incubation, photomicro-
graphs of cells were taken under inverted phase-contrast 
microscope.
α-Glucosidase inhibitory activity 
 The α-glucosidase inhibitory activity was esti-
mated by the modification of the procedure described 
by Matsui et al [24]. The α-glucosidase (Sigma-Aldrich 
St. Louis, MO, USA) solution was set at 400 mU/mL 
in a 0.1 M phosphate buffered saline (PBS) (pH=6.7). 
The tested extracts were diluted in the same phosphate 
buffer, so that the highest concentrations were 166.67 
μg/mL, from which serial double dilutions were made. 
Fifty μL of each extract in DMSO was diluted in 50 μL 
of enzyme at 37°C for 15 min. The reaction was started 
by adding 50 μL of substrate solution (1.5mg/mL PNP-G 
(p-nitrophenyl α-D-glucopyranoside, Sigma-Aldrich, St. 
Louis, MO, USA) in the buffer. After measuring absorb-
ance A1 at 405 nm, the solution was incubated at 37°C 
for 15 min. Second absorbance A2 was measured at 405 
nm. Acarbose (Sigma-Aldrich St. Louis, MO, USA) was 
used as positive control. The percentage of the enzyme 
inhibition was calculated according to the equation 
100×(A2S–A1S)/(A2B-A1B), where A1B, A2B and A1S, 
A2S represent the absorbance of the blank (phosphate 
buffer, DMSO, enzyme dilution, and PNP-G dilution) and 
the sample, respectively. All experiments were done in 
triplicate. 
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Antimicrobial activity
 Bacterial inoculi and suspensions of fungal spores 
were prepared as described by Kosanic et al [25] and 
according to the procedure recommended by NCCLS 
[26]. The minimal inhibitory concentration (MIC) was 
determined by broth microdilution method with using 
96-well micro-titer plates [27]. A series of dilutions with 
concentrations ranging from 25 to 0.012 mg/mL for test 
samples were used in the experiment against every mi-
croorganism tested. The starting solutions of the test 
samples were obtained by measuring certain quantity 
of extract and dissolving it in DMSO. As a positive con-
trol of growth inhibition, streptomycin and ketoconazole 
were used. A DMSO solution was used as a negative 
control for the influence of the solvents. All experiments 
were performed in triplicate.
Statistics
 The results are expressed as mean±standard devia-
tion of three independent experiments. Statistical analy-
ses were performed using one-way ANOVA with Dun-




 Fatty acid content was determined in the petro-
leum-ether fraction of the Fucus spiralis since this 
solvent is known as the most effective for isolation 
of fatty acids. The obtained results are presented 
in Table 1. Saturated fatty acids (SFA) with the 
highest content were palmitic and myristic acids. 
Among the examined monounsaturated acids the 
oleic acid was the most abundant. The following 
polyunsaturated fatty acids (PUFA) were detected 
in the fraction: eicosadienoic acid, arachidonic acid 
(AA), eicosapentaenoic acid (EPA), alfa linolenic 
acid (ALA), and linoleic acid (LA). PUFA to SFA ra-
tio was 0.50.
Total phenolic content and DPPH radical scavenging 
activity 
 The total phenolic contents and DPPH radi-
cal scavenging activities of Fucus spiralis extract 
and fractions are shown in Figure 1. The n-butanol 
fraction had the highest total phenolic content 
(15.16±0.04 mg GAE/g), followed by Fucus spiralis 
whole extract (7.11±0.06 mg GAE/g), ethyl-acetate 
(6.14±0.10 mg GAE/g) and petroleum-ether frac-
tion (3.62±0.03 mg GAE/g) (Figure 1). The ethyl-
acetate fraction showed the highest DPPH free 
radical scavenging activity (9.48±2.17) mg/mL, 
followed by Fucus spiralis whole extract (9.78±0.2 
mg/mL), petroleum-ether (15.67±0.11 mg/mL) and 
n-butanol fraction (21.16±2.77 mg/mL).
In vitro cytotoxicity
 Results of the examination of the cytotoxic ac-
tivities of the extract and fractions are presented 
in Table 2. HeLa cells were the most sensitive to 
Fatty acids F. spiralis %
Myristic acid C 14:0 16.24
pentadecanoic acid C 15:0 0.7
palmitic acid C 16:0 27.77
stearic acid C 18:0 1.87
∑SFA ∑SFA 46.58
palmitoleic acid C 16:1 1.08
oleic acid C 18:1 n-9 24.15
∑MUFA ∑MUFA 25.23
linoleic acid (LA) C 18:2 n-6 3.27
alfa linolenic acid (ALA) C 18:3 n-3 3.57
eicosadienoic acid C 20:2 n-6 6.32
arachidonic acid (AA) C 20:4 n-6 6.15







SFA: saturated fatty acids, MUFA: monounsaturated fatty acids, PUFA: polyunsaturated fatty acids
Table 1. Fatty acid content of the Fucus spiralis (petroleum-ether fraction) 
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the cytotoxic effects of the tested extract and frac-
tions. The strongest cytotoxic activity on HeLa 
cells was exerted by the Fucus spiralis petroleum-
ether fraction with IC50 value of 43.74±7.85 μg/mL, 
followed by the ethyl-acetate fraction (47.25±1.32 
μg/mL) and dichloromethane-methanol extract 
with (52.18±3.21μg/mL) and n-butanol (105±6.77 
μg/mL). All tested samples exerted lower intensity 
of the cytotoxic activity on LS174T and A549 cells 
when compared with their activities on HeLa cells. 
The ethyl-acetate fraction was the most active on 
LS174 cells with IC50 value of 72.58±0.55 μg/mL, 
followed by dichloromethane-methanol extract 
(81.75±4.60 μg/mL), petroleum-ether (85.12±3.49 
μg/mL) and n-butanol (159.00±1.45 μg/mL) frac-
tions. A549 cells were the most susceptible to 
the cytotoxic action of the ethyl-acetate fraction 
(132.68±3.93 μg/mL), then to the petroleum-ether 
(142.99±0.37 μg/mL), dichloromethane-methanol 
extract (147.41±1.25 μg/mL) and n-butanol (>200 
μg/mL) fraction. Each of the tested extract and frac-
tions exhibited notably lower intensity of the cyto-
toxic activity on normal MRC5 cells in comparison 
with their activity on the cancer cell lines. 
Cell cycle analysis
 Analysis of the cell cycle of HeLa cells treated 
with IC50 of the extract and fractions after 24 h (Fig-
ure 2) showed that ethyl-acetate fraction induced 
the highest increase of HeLa cells in the subG1 
phase when compared with this percentage in the 
control untreated cells. This fraction also led to ac-
cumulation of cells in the G2/M cell cycle phase, 
compared to control cells. HeLa cells treated with 
petroleum-ether fraction showed the highest accu-
mulation in the G2/M phase and induced increase 
of treated cells in the subG1 phase. The extract and 
n-butanol fraction also induced increase of HeLa 
cells within the subG1 phase. When treated with 
2×IC50 concentrations, the highest increase of HeLa 
cells within the subG1 phase was shown in cells 
treated with ethyl-acetate and petroleum-ether 
Figure 1. Total phenolic content and DPPH radical scavenging activity of algal extract and fractions (****p< 0.0001, 
***p< 0.001).
F. spiralis / IC50, µg/mL* HeLa LS174T A549 MRC5
extract 52.18±3.21 81.75±4.60 147.41±1.25 >200
petroleum-ether 43.74±7.85 85.12±3.49 142.99±0.37 >200
ethyl-acetate 47.25±1.32 72.58±0.55 132.68±3.393 >200
n-butanol 105.25 ±6.77 159.89±1.45 >200 >200
*Concentrations of the examined extract and fractions inducing 50% decrease in cell survival rate (expressed as IC50 value). Extracts were 
incubated with cells for 72 h, followed by cytotoxic activity determination in vitro by the MTT assay. Results are presented as the mean value 
± SD of three independent experiments.
Table 2. IC50 values for the investigated extract and fractions
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fractions. The extract and n-butanol fraction also 
induced increase in the percentage of cells in the 
subG1 cell cycle phase. Furthermore, accumulation 
of cells in the G2/M phase was observed in HeLa 
cells incubated in the presence of petroleum-ether 
and ethyl-acetate fractions, and whole extract. 
Fluorescence microscopy
 Morphological analysis by fluorescence mi-
croscopy showed that the majority of HeLa cells 
after treatment with extract and fractions were 
detached from cover slips, and therefore the su-
pernatant samples were analyzed (Figure 3). Con-
trol untreated cells were still attached to the cov-
er slips and had normal morphology. HeLa cells 
treated with 2×IC50 concentrations of Fucus spira-
lis extract and fractions showed typical signs of 
apoptosis: cells had round shape, their membrane 
was blebbing, and their nuclei were condensed or 
fragmented. In addition, orange-red stained cells 
were observed showing the signs of late apopto-
sis (apoptotic bodies) and secondary necrosis. The 
ethyl acetate fraction exhibited the strongest proa-
poptotic effect.
In vitro scratch assay
 The influence of the Fucus spiralis extract and 
fractions on the migration of endothelial EA.hy926 
cells was examined by in vitro scratch assay. The 
ethyl-acetate fraction showed the best antimigra-
tory activity (percentage of gap reduction was 
2.34±2.11), followed by the dichloromethane-
methanol extract (6.85±0.64%), and petroleum-
ether fraction (8.00±5.07%), while n-butanol frac-
Figure 2. Changes in cell cycle phase distribution of HeLa cells induced by the Fucus spiralis extract and fractions 
after 24-h treatment (treated cell samples were compared with control cell sample (****p<0.0001, ***p<0.001, **p<0.01, 
*p<0.05). 
Figure 3. Fluorescence photomicrographs of acridine orange-ethidium bromide stained HeLa cells 24 h after treatment 
with 2×IC50 concentration of F.spiralis extracts and fractions; 1: control, 2: extract (supernatant), 3: petroleum-ether 
fraction (supernatant), 4: ethyl-acetate fraction (supernatant), 5: n-butanol fraction (supernatant). Control cells are at-
tached to the cover slips and have normal morphology. The majority of HeLa cells after treatment are detached from 
cover slips. Cells treated with 2×IC50 concentration of F.spiralis extract and fractions showed typical signs of apoptosis: 
cells are rounded, with blebbing membrane and condensed or fragmented nuclei. Orange-red stained cells present late 
apoptosis (apoptotic bodies) and secondary necrosis.
Fucus spiralis has anticancer activity 1225
JBUON 2020; 25(2): 1225
tion exerted the poorest effect (46.20±3.56%); the 
percentage of gap reduction in control cells was 
57.60±1.83 (Figure 4). 
Tube formation assay
 Endothelial cell tube formation assay was used 
to examine the in vitro antiangiogenic properties 
of Fucus spiralis extract and fractions. As can be 
seen in Figure 5, the Fucus spiralis whole extract, 
petroleum-ether, and ethyl-acetate fractions in-
hibited elongation and connections of endothelial 
EA.hy926 cells grown on the surface of matrigel 
matrix, and also prevented their organization into 
tubular structures. Control cells and cells treated 
with n-butanol fraction showed formation of large 
vessel structures and complex meshes.
α-glucosidase inhibitory activity
 α-glucosidase inhibitory activity of the test-
ed extract and fractions is shown in Table 3. The 
Fucus spiralis extract and fractions showed strong 
α-glucosidase inhibitory activities. The best activi-
ty was observed for ethyl-acetate fraction, followed 
by petroleum-ether fraction, whole Fucus spiralis 
extract and n-butanol fraction. These results were 
much better than standard drug acarbose. The test-
ed algal samples demonstrated significantly better 
α-glucosidase inhibitory activity when compared 
with the activity of standard drug acarbose.
Microbiology
 Results of microbiology analysis are shown 
in Tables 4 and 5. Best antibacterial activity ex-
hibited n-butanol fraction (from 0.04 mg/mL for 
B.cereus and B.subtilis to 0.14 for P.mirabilis and 
E.coli), followed by ethyl-acetate (from 0.06 mg/mL 
for B.cereus to 0.47 mg/mL for E.coli), petroleum-
ether (from 0.17 mg/mL for B. cereus and B.subtilis 
to 1.33 mg/mL for E.coli) and whole Fucus spiralis 
extract (from 0.12 mg/mL for B.cereus to 0.95 mg/
mL for E.coli). N-butanol fraction was also most 
effective against the tested fungal strains (from 
0.14 mg/mL for T. mentagrophytes and C.albicans to 
0.56 for M. mucedo and A. niger), followed by ethyl 
acetate (from 0.19 mg/mL for C. albicans to 1.53 
for M. mucedo), petroleum-ether (from 0.33 mg/mL 
for C. albicans to 2.67 for M. mucedo and A. niger) 
and whole Fucus spiralis extract (from 0.95 mg/
mL for T.mentagrophytes to 3.78 for M. mucedo and
A. niger). 
Discussion
 Marine macroalgae have shown excellent cy-
totoxic activities and their dietary consumption is 
believed to be chemopreventive against several 
Figure 4. Scratch assay result chart showing percent-
ages of gap reduction with or without treatments of F. 
spiralis dichloromethane-methanol extract and fractions 
(****p<0.0001, **p<0.001).






Table 3. The IC50 values of the α-glucosidase inhibitory 
activity of the extracts and fractions
Figure 5. Light microscopy micrographs of EA.hy926 cells incubated in the presence of F.spiralis dichloromethane-
methanol extract and their fractions after 24 h. 1: control, 2: extract, 3: petroleum-ether fraction, 4: ethyl-acetate fraction, 
5: n-butanol fraction. Control ea.hy926 cells and cells treated with n-butanol fraction showed formation of large vessel 
structures and complex meshes. F.spiralis extract, petroleum-ether, and ethyl-acetate fractions inhibited elongation and 
connections of endothelial cells.
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cancer types (breast cancer, gastrointestinal, and 
skin cancers) [28,29]. 
 Our results showed that Fucus spiralis is rich 
in fatty acids and has fair amount on PUFAs. Other 
researchers have found that PUFA to SFA ratio in 
Fucus spiralis extract vary due to the season and 
place they were harvested [30]. It is observed that 
algae found in warm waters have more SFA than 
the ones grown in cold waters, and that season 
influence contributes to different fatty acids pro-
file [31]. It has been shown that n-3 PUFAs may 
contribute to reduced cancer and cardiovascular 
risks. Consumption of fatty acids can lower the oc-
currence of chronic diseases like cancer, diabetes, 
obesity and heart diseases [32]. 
 Fucales and Fucus spiralis are known for their 
high phenolic content and antioxidative activities 
[4,33]. It is found that phlorotannins, the unique 
polyphenols found in brown algae have cytotoxic, 
antioxidative, antidiabetic, and antimicrobial prop-
erties [34,35]. Ethyl acetate is used to elute phlo-
rotannins [36]. In this research, the ethyl-acetate 
fraction showed the highest DPPH free radical 
scavenging activity despite the fact that the n-bu-
tanol fraction had the highest total phenolic con-
tent. Although many studies have shown direct cor-
relation between total phenolic content and DPPH 
activity, many others didn’t find direct link [4, 37]. 
Beside polyphenols, other bioactive compounds 
can contribute to the antioxidative action of algal 
extracts and fractions [33]. In the same algal extract 
there are other components that exert synergistic 
or antagonistic effects on the radical scavenging 
activities [4]. Therefore, the type and content of dif-
ferent polyphenols in the extracts and their syner-
gistic or antagonistic actions should be taken into 
account when considering the bioactivity of the 
algal extracts and fractions. In 2010, Luo et al re-
ported that ethyl acetate and petroleum ether frac-
tions had the highest DPPH effects, suggesting that 
phenolic compounds with medium polarity might 
be major contributors to the antioxidative activity 
of brown seaweeds [38].
 Our results demonstrated that the algal extract 
and some fractions had pronounced and highly se-
lective cytotoxic activity in HeLa cells, and less 
in LS174T and A549 cells. The best cytotoxic ac-
tivities were exerted in petroleum-ether and ethyl 
acetate fractions that have plenty of fatty acids and 
polyphenols. To the best of our knowledge, these 
are the first findings about anticancer activity of 
the extract and fractions obtained from Fucus spira-
lis from this region and their mechanism of action. 
Earlier studies have shown that also the fucoidan in 
the whole extract could be responsible for cytotoxic 
effects, since it was found that fucoidan from Sar-
gasum and Fucus vesiculosus reduced the viability 
of lung carcinoma cells and melanoma cells [39]. 
Also, Alves et al [40] showed cytotoxic activity of 
Fucus spiralis extract from Portugal shoreline on 
human hepatocellular carcinoma cells. It has been 
suggested that different classes of primary and sec-
Microorganisms Staphylococcus aureus Bacillus subtilis Bacillus cereus Escherichia coli Proteus mirabilis
F. spiralis  MIC
extract 0.47 0.24 0.12 0.95 0.47
petroleum-ether 0.33 0.17 0.17 1.33 0.67
ethyl-acetate 0.23 0.12 0.06 0.47 0.23
n-butanol 0.07 0.04 0.04 0.14 0.14
streptomycin 0.03 0.02 0.02 0.06 0.06
Minimum inhibitory concentration (MIC); values given as mg/mL for extracts and antibiotic
Table 4. The antibacterial activity of the extract and fractions
Microorganisms Mucor mucedo Trichophyton mentagrophytes Aspergilus niger Candida albicans Penicillium italicum
F. spiralis  MIC
extract 3.78 0.95 3.78 0.47 1.89
petroleum-ether 2.67 0.67 2.67 0.33 1.33
ethyl-acetate 1.53 0.38 0.76 0.19 1.53
n-butanol 0.56 0.14 0.56 0.14 0.28
ketokonazole 0.16 0.08 0.08 0.04 0.16
Minimum inhibitory concentration (MIC); values given as mg/mL for extracts and antimycotic
Table 5. The antifungal activity of the extract and fractions
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ondary metabolites such as terpenes, phenols, fatty 
acids, hydrocarbons, and fucoxanthin are responsi-
ble for the cytotoxic effects of Fucus spiralis extract 
on MCF-7 cells [41].
 The investigation of the effects on changes in 
cell cycle phases revealed that Fucus spiralis extract 
and fractions exerted pro-apoptotic effects in HeLa 
cells in a dose-dependent manner. Highest accu-
mulation of cells in the subG1 and G2/M phases 
were shown by ethyl-acetate and petroleum-ether 
fractions, rich in polyphenols and fatty acids. Both 
polyphenols and fatty acids are found to have proa-
poptotic effects and influence on cell cycle arrest 
[10,42,43]. Beside polyphenols and fatty acid influ-
ence on anticancer activities, fucoidan could be one 
of the active components in Fucus spiralis extract 
behind these activities. Fucoidan was found to in-
duce cell cycle arrest and apoptosis [7]. Further-
more, Kim et al [7] showed that fucoidan inhibited 
the proliferation of human colon cancer cells HT-29 
and HTC116 and induced apoptosis, while at the 
same time had no toxic effects on normal human 
colon FHC cells. Fucoidan could also have syner-
gistic effects with current anticancer agents thus 
preventing toxicity [44]. 
 Results of the in vitro scratch assay showed 
that ethyl-acetate fraction, followed by Fucus spi-
ralis extract and petroleum-ether fraction exerted 
the best antimigratory activity. These results may 
suggest that polyphenol and fatty acids contributed 
to the inhibition of migration of endothelial cells 
as found in the literature [10,43]. In 2012, Ferres et 
al showed that phlorotannins prevent cancer cell 
migrations [45]. Furthermore, fucoidan decreased 
metastasis in rats and in MDA-MB-231 cells [7,44].
 Antiangiogenic effects in our experiments 
were demonstrated by Fucus spiralis extract, ethyl-
acetate and petroleum-ether fractions. This may 
suggest the role of polyphenols and fatty acids as 
potential antiangiogenic agents, as confirmed by 
the literature data [10,46]. Also, we can’t exclude 
the role of fucoidan in the extract, as literature 
data report that it may suppress angiogenesis via 
inhibition of binding vascular endothelial growth 
factor (VEGF) to the cell membrane receptor [7,46].
 The tested extract and fractions showed similar 
effects and much better anti-α-glucosidase action 
than standard acarbose. Studies have shown that 
polyphenols, beside their ability to reduce oxida-
tive stress, can also inhibit the polysaccharide hy-
drolyzing enzymes, thus preventing hyperglyce-
mia [47,48]. It has been shown that fatty acids and 
phlorotannins can inhibit α-glucosidase [49]. Our 
results also indicate that other extract constituents, 
beside polyphenols, and fatty acids all together 
contributed to the high rate of α-glucosidase inhi-
bition. This result is in accordance with study of 
Fucus spiralis ethanol-based extract which showed 
α-glucosidase and amylase inhibitory activities 
[50]. 
 Microbiology results correlate with total phe-
nolic and fatty acids content of extract and fraction 
as n-butanol fraction had the highest phenolic con-
tent, and petroleum-ether fraction was rich in fatty 
acids. Literature data showed that polyphenols and 
fatty acids have antimicrobial activities [51,52]. Re-
searchers also found that phlorotannin rich extract 
and terpenes could be responsible for antimicrobial 
activities [53-55]. Earlier studies, using less sensi-
tive disk-diffusion method, also showed the Fucus 
spiralis antimicrobial action [8,56-58]. Etahiri et al 
in 2003 [59] recorded that seasonal variation had 
influence on antibacterial activity and that algae 
collected in March to May had better antibacte-
rial activity than algae collected in December and 
January. 
Conclusion
 The extract and fractions obtained from Fucus 
spiralis showed cytotoxic effects against cancer cell 
lines, while at the same time they were less toxic 
against normal MRC-5 fibroblasts. The strongest 
cytotoxic activities was exerted in petroleum-ether 
fraction, ethyl-acetate fraction, and dichlorometh-
ane-methanol extract against HeLa cell line. These 
two fractions induced increase of HeLa cells within 
subG1 and G2/M cell cycle phases. Furthermore, 
they demonstrated antimigratory and antiangio-
genic effects in vitro. These results, in addition to 
other biological properties of tested extract and 
fractions, may suggest a promising anticancer and 
pharmacological potential of Fucus spiralis. 
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